NEW ANTIRHEUMATIC SUBSTANCE BASED ON PHENOLIC GLYCOSIDE STRUCTURE METHYL (4-О-Β-GLUCOPYRANOSYLOXY)-BENZOIC ACID

Authors

  • Nemtsev Alexey The Altay state university, Institute of Biomedicine, Lenin Avenue 61a, 656049 Barnaul. Russia
  • Smirnov Ivan The Altay state university, Institute of Biomedicine, Lenin Avenue 61a, 656049 Barnaul. Russia
  • Murashko Tatyana The Altay state university, Institute of Biomedicine, Lenin Avenue 61a, 656049 Barnaul. Russia
  • Ivanov Alexey National Research Tomsk Polytechnic University, Lenin Avenue 30, 634050, Tomsk. Russia
  • Bondarev Alex The Altay state university, Institute of Biomedicine, Lenin Avenue 61a, 656049 Barnaul. Russia
  • Udut Vladimir Institute of Pharmacology, Siberian Branch of the Russian Academy of Sciences, Lenin Avenue 3, 634028, Tomsk. Russia

DOI:

https://doi.org/10.11113/jt.v78.9058

Keywords:

Rheumatoid arthritis, NSAID, phenolic glycosides, adjuvant arthritis

Abstract

Rheumatoid arthritis (RA) is a chronic inflammatory multifactorial disorder affecting approximately 1% of population, with over 3000000 new cases annually. The principal pharmacological agents are nonsteroidal anti-inflammatory drugs (NSAID). Patients with rheumatoid arthritis are vulnerable to NSAID-associated gastrointestinal complications. Based on these findings we developed a new NSAID agent based on phenolic glycoside structure methyl (4-О-β-glucopyranosyloxy)-benzoic acid. In this study we evaluated the methyl (4-О-β-glucopyranosyloxy)-benzoic acid therapeutic effect in adjuvant-induced rat arthritis compared to etoricoxib effect. According to the results, methyl (4-О-β-glucopyranosyloxy)-benzoic acid activity was superior to etoricoxib, paw volume returned to the initial value 2 days early, than it did in etoricoxib group. Therefore, methyl (4-О-β-glucopyranosyloxy)-benzoic acid might contest to the modern antirheumatic drug etoricoxib. 

References

Asako, H., Kubes, P., Wallace, J., Gaginella, T., Wolf, R. E., Granger, D. N. 1992. Indomethacin-Induced Leukocyte Adhesion in Mesenteric Venules; Role of Lipoxygenase Products. Am. J. Physiol. 262: G903-G908.

Choi, H. K., Hernán, M. A., Seeger, J. D., Robins, J. M., Wolfe, F. 2002. Мethotrexate and Mortality in Patients with Rheumatoid Arthritis: A Prospectivestudy. Lancet. 359(9313): 1173-1177.

Escandell, J. M., Recio, M. C., Manez, S., Giner, R. M., Cerda-Nicolas, M., Rios, J. L. Cucurbitacin, R. 2007. Reduces The Inflammation And Bone Damage Associated with Adjuvant Arthritis In Lewis Rats by Suppression of Tumor Necrosis Factor-Alpha in T Lymphocytes and Macrophages. J.Pharmacol. Exp. Ther. 320: 581-590.

Fries, J. F., Miller, S. R., Spitz, P. W., Williams, C. A., Hubert, H. B., Bloch, D. A. 1989. Toward an Epidemiology of Gastropathy Associated with Nonsteroidalanti Inflammatory Drug Use. Gastroenterology. 96 (Suppl): 647-655.

Hultqvist, M., Olofssёon, P., Gelderman, K. A., Holmberg, J., Holmdahl, R. 2006. A New Arthritis Therapy with Oxidative Burst Inducers. PLoS Med. 3: e348.

Kameshwari, J. S., and Raju Devde. 2015. A Case Report on Toxic Epidermal Necrolysis with Etoricoxib. Indian Journal Of Pharmacology. 47(2): 221.

Kato, N., Mashita, Y., Kato, S., Mitsufuji, S., Yoshikawa, T., Takeuchi, K., Sildenafil. 2009. An Inhibitor of Phosphodiesterase Subtype 5, Prevents Indomethacin-Induced Small-Intestinal Ulceration in Rats Via A NO/Cgmp-Dependent Mechanism. Dig. Dis. Sci. 54: 2346-2356.

Kato, S., Ito, Y., Nishio, H., Aoi, Y., Amagase, K., Takeuchi, K. 2007. Increased Susceptibility of Small Intestine to NSAID-Provoked Ulceration in Rats with Adjuvant-Induced Arthritis: Involvement of Enhanced Expression of TLR4. LifeSci. 81: 1309-1316.

Kato, S., Ohkawa, F., Ito, Y., Amagase, K., Takeuchi, K. 2009. Role of Endothelial Nitric Oxide Synthase in Aggravation of Indomethacin-Induced Gastric Damage in Adjuvant Rthritic Rats. J. Physiol. Pharmacol. 60: 147-155.

Kato, S., Takeuchi, K. 2002. Alteration of Gastric Ulcerogenic and Healing Responses in Rats with Adjuvant-Induced Arthritis. Jpn. J. Pharmacol. 89: 1-6.

Konaka, A., Nishijima, M., Tanaka, A., Kunikata, T., Kato, S., Takeuchi, K. 1999. Nitric Oxide, Superoxide Radicals and Mast Cells in Pathogenesis of Indomethacin Induced Intestinal Lesions in Rats. Journal of Pharmacology and Physiology. 50: 25-38.

Kothavade, Pankaj, S., et al. 2015. Therapeutic Effect of Saponin Rich Fraction of Achyranthes aspera Linn. on Adjuvant-Induced Arthritis in Sprague-Dawley Rats. Autoimmune Diseases.

Kvien, Tore, K., et al. 2015. Do COX-2 Inhibitors Provide Additional Pain Relief And Anti-Inflammatory Effects In Patients With Rheumatoid Arthritis Who Are On Biological Disease-Modifying Anti-Rheumatic Drugs And/Or Corticosteroids? Post-Hoc Analyses from a Randomized Clinical Trial with Etoricoxib. BMC Musculoskeletal Disorders 16(1): 26.

Lee, B. H. et al. 2014. Difficult Establishment of a Chronic Nonsteroidal Anti-inflammatory Drugs Induced Gastric Inflammation Rat Model due to Gastric Adaptation and Small Bowel Damage. The Korean Journal of Gastroenterology. 63(6): 341-347.

Mossiat, Claude, et al. 2015. Association between Arthritis Score at the Onset of the Disease and Long-Term Locomotor Outcome in Adjuvant-Induced Arthritis in Rats. Arthritis research & Therapy. 17(1): 1-12.

Nagai, N., Fukuhata, T., Ito, Y., Usui, S., Hirano, K. 2009. Involvement of Interleukin 18 in Indomethacin-Induced Lesions of the Gastric Mucosa in Adjuvant-Induced Arthritis Rat. Toxicology. 255: 124-130.

Rachana, P. R., H. V. Anuradha, and Reddy Mounika. 2015. Stevens Johnson Syndrome-Toxic Epidermal Necrolysis Overlap Secondary to Interaction between Methotrexate and Etoricoxib: A Case Report. Journal Of Clinical And Diagnostic Research. JCDR. 9(7): FD01.

S. L. Kunkel, N. Lukacs, T. Kasama, and R. M. Strieter. 1996. The role of Chemokines in Inflammatory Joint Disease. Journal of Leukocyte Biology. 59(1): 6-12.

Scott, D. L., Wolfe, F., Huizinga, T. W. J. 2010. Rheumatoidarthritis. Lancet. 376(9746): 1094-1108.

Soni, M. G., I. G. Carabin, andG. A. Burdock. 2005. Safety Assessment of Esters of P-Hydroxybenzoic Acid (Parabens). Food and Chemical Toxicology. 43(7): 985-1015.

Vane, J. R. 197. Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-Like Drugs. Nat. NewBiol. 23: 232-235.

Weissenborn, U., Maedge, S., Buettner, D., Sewing, K. F. 1985. Indomethacinincreased Gastrointestinal Lesions In Relation To Tissue Concentration, Food Intake and Bacterial Invasion in The Rat. Pharmacology. 30: 32-39.

Whittle, B. J., Laszlo, F., Evans, S. M., Moncada, S. 1995. Induction of Nitric Oxide Synthase and Microvascular Injury in the Rat Jejunum Provoked By Indomethacin. Br. J. Pharmacol. 116: 2286-2290.

Whittle, B. J. 1981. Temporal Relationship between Cyclooxygenase Inhibition, As Measured by Prostacyclin Biosynthesis, and The Gastrointestinal Damage Induced by Indomethacin in The Rat. Gastroenterology. 80: 94-98.

Yamada, T., Deitch, E., Specian, R. D., Perry, M. A., Sartor, R. B., Grisham, M. B. 1993. Mechanisms of Acute and Chronic Intestinal Inflammation Induced By Indomethacin. Inflammation. 17: 641-662.

Downloads

Published

2016-06-13

Issue

Section

Science and Engineering

How to Cite

NEW ANTIRHEUMATIC SUBSTANCE BASED ON PHENOLIC GLYCOSIDE STRUCTURE METHYL (4-О-Β-GLUCOPYRANOSYLOXY)-BENZOIC ACID. (2016). Jurnal Teknologi, 78(6-8). https://doi.org/10.11113/jt.v78.9058